Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Angela DM. Kashuba"'
Autor:
Patrick O. Hanafin, Brian Jermain, Anthony J. Hickey, Alexander V. Kabanov, Angela DM. Kashuba, Timothy P. Sheahan, Gauri G. Rao
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 2, Pp 89-99 (2021)
Abstract The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) outbreak initiated the global coronavirus disease 2019 (COVID‐19) pandemic resulting in 42.9 million confirmed infections and > 1.1 million deaths worldwide as of October
Externí odkaz:
https://doaj.org/article/bda925b05d3b4d6ab7b8cfb0cdce9b1b
Autor:
Elias P. Rosen, Nicole White, William M. Gilliland, Roy R. Gerona, Monica Gandhi, K. Rivet Amico, Kenneth H. Mayer, Roy M. Gulick, Angela DM Kashuba
Objective measures of adherence for antiretrovirals used as pre-exposure prophylaxis (PrEP) are critical for improving preventative efficacy in both clinical trials and real-world application. Current objective adherence measures either reflect only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e724c956fab54642a07711d1c95d4c9
https://doi.org/10.1101/2023.01.30.526384
https://doi.org/10.1101/2023.01.30.526384
Autor:
Amanda P. Schauer, Craig Sykes, Mackenzie L. Cottrell, Arkaitz Imaz, Daniel Podzamczer, Angela DM Kashuba
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 220
Bictegravir (BIC), an integrase inhibitor, and doravirine (DOR), a non-nucleoside reverse transcriptase inhibitor, were recently approved by the US FDA for HIV treatment and are recommended first line treatment options. Because certain clinical scena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d0c161731ff1ffe38b67002fd08c4c1
https://pubmed.ncbi.nlm.nih.gov/36030752
https://pubmed.ncbi.nlm.nih.gov/36030752
Autor:
Julie B Dumond, Stephen A Greene, Heather Prince, Jingxian Chen, Brian M Maas, Craig Sykes, Amanda P Schauer, Kimberly H Blake, Julie AE Nelson, Cynthia L Gay, Angela DM Kashuba, Myron S Cohen
Publikováno v:
Antiviral Therapy. 24:45-50
Background The male genital tract (MGT) is a viral sanctuary and likely HIV reservoir; understanding MGT pharmacokinetics (PK) of antiretrovirals (ARVs) used for curative strategies is critical to eradication and cure. Tenofovir alafenamide (TAF) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::963bbbbf2b48bc33fe0d9b59ef796383
https://doi.org/10.3851/imp3277
https://doi.org/10.3851/imp3277
Autor:
John T Mitchell, Sara LeGrand, Lisa B Hightow-Weidman, Mehri S. McKellar, Angela DM Kashuba, Mackenzie Cottrell, Tony McLaurin, Goutam Satapathy, F Joseph McClernon
BACKGROUND Pre-exposure prophylaxis (PrEP) provides a strong preventative benefit to individuals at risk for HIV. While PrEP adherence is highly correlated with its efficacy, adherence rates are variable both across and within persons. OBJECTIVE The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::993ddb61990607097651fe42a4ddbcc6
https://doi.org/10.2196/preprints.10456
https://doi.org/10.2196/preprints.10456
Autor:
Michael D Weber, Elizabeth Andrews, Heather A Prince, Craig Sykes, Elias P Rosen, Camden Bay, Nicholas J Shaheen, Ryan D Madanick, Evan S Dellon, Kristina De Paris, Julie AE Nelson, Cynthia L Gay, Angela DM Kashuba
Publikováno v:
Antivir Ther
Background Raltegravir (RTG) and dolutegravir (DTG) have different pharmacokinetic patterns in the gastrointestinal tract. To determine if this results in pharmacodynamic differences, we compared HIV RNA, HIV DNA and immunological markers in gut-asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f5cba2dd24486a6c2926071be1b0e64
https://europepmc.org/articles/PMC7376574/
https://europepmc.org/articles/PMC7376574/
Autor:
Oramasionwu CU; Christine U Oramasionwu, Angela DM Kashuba, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States., Kashuba AD; Christine U Oramasionwu, Angela DM Kashuba, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States., Napravnik S; Christine U Oramasionwu, Angela DM Kashuba, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States., Wohl DA; Christine U Oramasionwu, Angela DM Kashuba, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States., Mao L; Christine U Oramasionwu, Angela DM Kashuba, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States., Adimora AA; Christine U Oramasionwu, Angela DM Kashuba, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, United States.
Publikováno v:
World journal of hepatology [World J Hepatol] 2016 Mar 08; Vol. 8 (7), pp. 368-75.